Mitchell Sinkler & Starr Amgen Inc Transaction History
Mitchell Sinkler & Starr
- $353 Million
- Q1 2025
A detailed history of Mitchell Sinkler & Starr transactions in Amgen Inc stock. As of the latest transaction made, Mitchell Sinkler & Starr holds 2,335 shares of AMGN stock, worth $676,145. This represents 0.21% of its overall portfolio holdings.
Number of Shares
2,335
Previous 4,085
42.84%
Holding current value
$676,145
Previous $1.06 Million
31.67%
% of portfolio
0.21%
Previous 0.29%
Shares
8 transactions
Others Institutions Holding AMGN
# of Institutions
3,310Shares Held
429MCall Options Held
8.06MPut Options Held
7.7M-
Vanguard Group Inc Valley Forge, PA52.9MShares$15.3 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$13.3 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.2MShares$8.45 Billion0.38% of portfolio
-
Capital World Investors Los Angeles, CA16.7MShares$4.84 Billion0.88% of portfolio
-
Morgan Stanley New York, NY16.2MShares$4.7 Billion0.37% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $155B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...